Literature DB >> 17321323

Comprehensive cytogenetic characterization of an esthesioneuroblastoma.

Heidrun Holland1, Ronald Koschny, Wolfgang Krupp, Jürgen Meixensberger, Manfred Bauer, Holger Kirsten, Peter Ahnert.   

Abstract

Esthesioneuroblastoma is a malignant neuroectodermal tumor originating from olfactory epithelial cells in the nasal vault. Due to the rarity of this tumor entity, cytogenetic data are very limited. Therefore, we performed comprehensive cytogenetic analyses of an esthesioneuroblastoma, Hyam's grade III-IV, using trypsin-Giemsa staining (GTG banding), multicolor fluorescence in situ hybridization (M-FISH), and locus-specific FISH complemented by molecular karyotyping using high-density single nucleotide polymorphism arrays. GTG banding of 25 metaphases revealed 54 structural intrachromosomal aberrations, predominantly located on 2q, 6q, 21q, and 22q, which were confirmed by FISH analysis. Interestingly, we found two novel, so far not described deletions, del(2)(q37) and del(21)(q22). Using GTG banding, locus-specific FISH, and M-FISH, we detected numeric changes of chromosomes 5, 17, 19, and 22, as well as trisomy 8 at low frequency. Applying SNP array karyotyping, we confirmed the chromosomal aberrations del(2)(q37.3), del(3)(q27.2), del(10)(q26.11), chromosomal imbalance on 17q, del(21)(q22), and revealed a number of so far unknown aberrations (gain of 2q14.3, 13q33.3, and 13q34). While the cytogenetically revealed low frequency mosaic del(6)(q22q24) was not visible using SNP array karyotyping, some of the smaller imbalances (SNP array data) could not have been detected by classic cytogenetic analysis. Therefore, our study supports the usefulness of applying complementary methods for cytogenetic analysis.

Entities:  

Mesh:

Year:  2007        PMID: 17321323     DOI: 10.1016/j.cancergencyto.2006.09.024

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  10 in total

Review 1.  Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma.

Authors:  Diana Bell
Journal:  Head Neck Pathol       Date:  2018-02-09

Review 2.  Olfactory Neuroblastoma.

Authors:  Ahmed S Abdelmeguid
Journal:  Curr Oncol Rep       Date:  2018-02-07       Impact factor: 5.075

3.  Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.

Authors:  Laurie M Gay; Sungeun Kim; Kyle Fedorchak; Madappa Kundranda; Yazmin Odia; Chaitali Nangia; James Battiste; Gerardo Colon-Otero; Steven Powell; Jeffery Russell; Julia A Elvin; Jo-Anne Vergilio; James Suh; Siraj M Ali; Philip J Stephens; Vincent A Miller; Jeffrey S Ross
Journal:  Oncologist       Date:  2017-05-11

Review 4.  The genomics and epigenetics of olfactory neuroblastoma: A systematic review.

Authors:  Raman Preet Kaur; Evgeny Izumchenko; Dukagjin M Blakaj; Nikol Mladkova; Matt Lechner; Thomas L Beaumont; Charalampos S Floudas; Gary L Gallia; Nyall R London
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-06-07

5.  Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis.

Authors:  Ronald Koschny; Heidrun Holland; Jaromir Sykora; Hande Erdal; Wolfgang Krupp; Manfred Bauer; Ulrike Bockmuehl; Peter Ahnert; Jürgen Meixensberger; Wolfgang Stremmel; Henning Walczak; Tom M Ganten
Journal:  J Neurooncol       Date:  2009-09-20       Impact factor: 4.130

Review 6.  Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment.

Authors:  Shirley Y Su; Diana Bell; Ehab Y Hanna
Journal:  Int Arch Otorhinolaryngol       Date:  2014-10

7.  Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.

Authors:  Jasmina Topcagic; Rebecca Feldman; Anatole Ghazalpour; Jeffrey Swensen; Zoran Gatalica; Semir Vranic
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

8.  Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma.

Authors:  Gary L Gallia; Ming Zhang; Yi Ning; Michael C Haffner; Denise Batista; Zev A Binder; Justin A Bishop; Christine L Hann; Ralph H Hruban; Masaru Ishii; Alison P Klein; Douglas D Reh; Lisa M Rooper; Vafi Salmasi; Rafael J Tamargo; Qing Wang; Tara Williamson; Tianna Zhao; Ying Zou; Alan K Meeker; Nishant Agrawal; Bert Vogelstein; Kenneth W Kinzler; Nickolas Papadopoulos; Chetan Bettegowda
Journal:  Nat Commun       Date:  2018-12-21       Impact factor: 14.919

9.  Dramatic response to targeted therapy in an aggressive olfactory neuroblastoma: illustrative case.

Authors:  Saksham Gupta; Wenya Linda Bi; Donald J Annino; Ian F Dunn
Journal:  J Neurosurg Case Lessons       Date:  2022-06-13

Review 10.  Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.

Authors:  Piotr Czapiewski; Michał Kunc; Johannes Haybaeck
Journal:  Oncotarget       Date:  2016-08-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.